Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 152
Filtrar
3.
Genes (Basel) ; 12(5)2021 05 13.
Artigo em Inglês | MEDLINE | ID: mdl-34068220

RESUMO

Calcium (Ca) and Phosphorus (P) hold a leading part in many skeletal and extra-skeletal biological processes. Their tight normal range in serum mirrors their critical role in human well-being. The signalling "voyage" starts at Calcium Sensing Receptor (CaSR) localized on the surface of the parathyroid glands, which captures the "oscillations" of extracellular ionized Ca and transfers the signal downstream. Parathyroid hormone (PTH), Vitamin D, Fibroblast Growth Factor (FGF23) and other receptors or ion-transporters, work synergistically and establish a highly regulated signalling circuit between the bone, kidneys, and intestine to ensure the maintenance of Ca and P homeostasis. Any deviation from this well-orchestrated scheme may result in mild or severe pathologies expressed by biochemical and/or clinical features. Inherited disorders of Ca and P metabolism are rare. However, delayed diagnosis or misdiagnosis may cost patient's quality of life or even life expectancy. Unravelling the thread of the molecular pathways involving Ca and P signaling, we can better understand the link between genetic alterations and biochemical and/or clinical phenotypes and help in diagnosis and early therapeutic intervention.


Assuntos
Distúrbios do Metabolismo do Cálcio/genética , Distúrbios do Metabolismo do Fósforo/genética , Animais , Cálcio/metabolismo , Distúrbios do Metabolismo do Cálcio/metabolismo , Distúrbios do Metabolismo do Cálcio/patologia , Fator de Crescimento de Fibroblastos 23 , Humanos , Mutação , Fósforo/metabolismo , Distúrbios do Metabolismo do Fósforo/metabolismo , Distúrbios do Metabolismo do Fósforo/patologia
4.
Nutrients ; 13(2)2021 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-33670005

RESUMO

BACKGROUND: Due to the potentially crucial role of vitamin K2 in calcium metabolism, a deficit can disrupt many mechanisms, resulting in an array of different issues, such as broken bones, stiff arteries and poor fertility. Although there has been existing research, the potential of vitamin K2 as a treatment for conditions including cerebral palsy, parathyroid disease, heart disease and gastrointestinal disease is unknown. This review discusses the biochemistry of vitamin K and the metabolism of calcium, followed by an analysis of the current literature available on vitamin K2 and its prospects. METHODS: Using public libraries including PubMed and Wiley, we searched for existing research on the metabolism and use of vitamin K2 that has been conducted in the preceding two decades. RESULTS: Data indicated that vitamin K2 had a positive impact on osteoporosis, cardiovascular disease, parathyroid disorders, cerebral palsy and sperm motility. CONCLUSION: Due to the existence of confounding variables and limitations in the quality and volume of research conducted, further investigation must be done to see whether the beneficial effects seen are reproducible and must assess the viability of vitamin K2 as treatment in isolation for these conditions.


Assuntos
Distúrbios do Metabolismo do Cálcio/tratamento farmacológico , Cálcio/metabolismo , Vitamina K 2/farmacologia , Vitaminas/farmacologia , Distúrbios do Metabolismo do Cálcio/metabolismo , Paralisia Cerebral/tratamento farmacológico , Paralisia Cerebral/terapia , Gastroenteropatias/tratamento farmacológico , Gastroenteropatias/metabolismo , Cardiopatias/tratamento farmacológico , Cardiopatias/metabolismo , Humanos , Doenças das Paratireoides/tratamento farmacológico , Doenças das Paratireoides/metabolismo
5.
J Appl Lab Med ; 5(4): 704-715, 2020 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-32603436

RESUMO

BACKGROUND: Total calcium is a less accurate test in predicting ionized calcium (Ca2+) in patients suspected of calcium metabolic disease. Nevertheless, total calcium continues to be used as routine measurement instead of adjusted Ca2+ (at pH 7.4). In the current study we evaluate a new multichannel instrument, the ISE Module E1200 for adjusted Ca2+ (at pH 7.4), containing three different ion-selective electrode (ISE) units. METHODS: Serum from 1350 patients was compared to the ABL835 flex and KoneLab. Total calcium was also evaluated on the Dimension Vista 1500 system. Correlations between instruments were assessed by Deming regression and degree of agreement by Cohen's kappa (κ). RESULTS: Analytical imprecisions for the three ISE units for adjusted Ca2+ (at pH 7.4) was between 0.36% and 2.52%, and for pH between 0.32% and 3.24%. Results were comparable for each ISE unit (r = 0.797-0.917; all P < 0.0001) and in high-throughput settings (r = 0.871; P < 0.0001). The degree of agreement between instruments was moderate to good (κ = 0.52-0.77). In contrast, there was a very poor agreement (κ = -0.14) for total calcium with discrepancy in 53.4% of the samples. CONCLUSIONS: The new ISE Module E1200 is comparable with the ABL835 flex and KoneLab 30i and therefore may be used for routine analysis of serum adjusted Ca2+ (at pH 7.4). The measured adjusted Ca2+ (at pH 7.4) was less comparable with very poor agreement to total calcium measured on the Dimension Vista 1500 system.


Assuntos
Análise Química do Sangue/instrumentação , Distúrbios do Metabolismo do Cálcio/diagnóstico , Cálcio/sangue , Ensaios de Triagem em Larga Escala/instrumentação , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Cálcio/metabolismo , Distúrbios do Metabolismo do Cálcio/sangue , Distúrbios do Metabolismo do Cálcio/metabolismo , Cátions Bivalentes/sangue , Criança , Pré-Escolar , Feminino , Humanos , Concentração de Íons de Hidrogênio , Eletrodos Seletivos de Íons , Masculino , Pessoa de Meia-Idade , Adulto Jovem
6.
J Alzheimers Dis ; 67(1): 137-147, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30636740

RESUMO

BACKGROUND: Disruption of intracellular Ca2+ homeostasis and associated autophagy dysfunction contribute to neuropathology in Alzheimer's disease (AD). OBJECTIVE: To study the effects of propofol on cell viability via its effects on intracellular Ca2+ homeostasis, and the impact of autophagy, in a neuronal model of presenilin-mutated familial AD (FAD). METHODS: We treated PC12 cells, stably transfected with either mutated presenilin-1 (L286V) or wild type (WT) controls, with propofol at different doses and durations, in the presence or absence of extracellular Ca2+, antagonists of inositol trisphosphate receptors (InsP3R, xestospongin C) and/or ryanodine receptors (RYR, dantrolene), or an inhibitor of autophagy flux (Bafilomycin). We determined cell viability, cytosolic Ca2+ concentrations ([Ca2+]c), vATPase protein expression, and lysosomal acidification. RESULTS: The propofol dose- and time-dependently decreased cell viability significantly more in L286V than WT cells, especially at the pharmacological dose (>50µM), and together with bafilomycin (40 nM). Clinically used concentrations of propofol (<20µM) tended to increase cell viability. Propofol significantly increased [Ca2+]c more in L286V than in WT cells, which was associated with decrease of vATPase expression and localization to the lysosome. Both toxicity and increased Ca2+ levels were ameliorated by inhibiting InsP3R/RYR. However, the combined inhibition of both receptors paradoxically increased [Ca2+]c, by inducing Ca2+ influx from the extracellular space, causing greater cytotoxicity. CONCLUSION: Impairment in autophagy function acts to deteriorate cell death induced by propofol in FAD neuronal cells. Cell death is ameliorated by either RYR or InsP3R antagonists on their own, but not when both are co-administered.


Assuntos
Doença de Alzheimer/genética , Anestésicos Intravenosos/toxicidade , Autofagia/genética , Distúrbios do Metabolismo do Cálcio/genética , Distúrbios do Metabolismo do Cálcio/patologia , Neurônios/efeitos dos fármacos , Síndromes Neurotóxicas/genética , Síndromes Neurotóxicas/patologia , Presenilina-1/genética , Propofol/toxicidade , Adenosina Trifosfatases/biossíntese , Animais , Distúrbios do Metabolismo do Cálcio/metabolismo , Humanos , Síndromes Neurotóxicas/metabolismo , Células PC12 , Ratos , Canal de Liberação de Cálcio do Receptor de Rianodina/efeitos dos fármacos
8.
Curr Med Chem ; 24(38): 4229-4244, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28901272

RESUMO

Prostate cancer significantly affects the overall morbidity and mortality of malignant tumours in highly developed countries. Important risk factors include family predisposition and regional, racial and dietary determinants. The scientific literature contains a great deal of data on the role of calcium and dairy products in general in the process of neoplastic transformation of the prostate. This is most likely linked to the fact that changes in the concentration of calcium ions control such varied life processes as secretion of hormones and neurotransmitters, the level of cyclic nucleotides, and cell growth, division and differentiation. Research is conducted to demonstrate that disorders of cell cycle control due to differences in calcium ion concentrations may be crucial for the development and prevention of cancer. Disturbances of calcium homeostasis in the body can be caused by various mechanisms, such as excessive calcium intake in the diet, vitamin D deficiency, structural and functional changes in vitamin D receptor (VDR), Calcium-Sensing Receptor (CaSR), and parathyroid hormone receptor (PTH-1-R), changes in calcium ion channels, phosphate metabolism disorders (phosphatonin and the Klotho protein), changes in the level of parathyroid hormone-related protein (PTHrP), and others. The article presents data on the mechanisms maintaining calcium homeostasis at the molecular level and genetic aspects playing a role in the pathogenesis of prostate cancer. The data cited on the occurrence of abnormal mechanisms of calcium metabolism in prostate cancer suggest the need for individualized intake of this element in the diet, especially in the case of patients with a family history of PCa.


Assuntos
Distúrbios do Metabolismo do Cálcio/metabolismo , Cálcio/metabolismo , Homeostase , Neoplasias da Próstata/metabolismo , Animais , Distúrbios do Metabolismo do Cálcio/genética , Humanos , Masculino , Neoplasias da Próstata/genética , Fatores de Risco
9.
Clin Calcium ; 27(4): 521-527, 2017.
Artigo em Japonês | MEDLINE | ID: mdl-28336828

RESUMO

Sensing of extracellular calcium(Ca2+)levels involves the Ca-sensing receptor(CaSR), its downstream signaling molecule Gα11, and the adaptor-related protein complex 2(AP2)that plays a role in clathrin-dependent endocytosis of CaSR. Inactivating mutations in CaSR cause familial hypocalciuric hypercalcemia type 1(FHH1)and neonatal severe hyperparathyroidism(NSHPT), while activating mutations lead to autosomal dominant hypocalcemia type 1(ADH1)and Bartter syndrome type Ⅴ. Recent studies have identified that inactivating mutations in Gα11 and σ-subunit of AP2(AP2σ)also cause FHH, and these conditions have been classified as FHH2 and FHH3, respectively. In addition, it has been revealed that activating mutations in Gα11 are responsible for ADH(ADH2). Calcimimetics and calcilytics may be beneficial in the treatment of these disorders.


Assuntos
Distúrbios do Metabolismo do Cálcio/metabolismo , Mutação , Receptores de Detecção de Cálcio/metabolismo , Cálcio/metabolismo , Distúrbios do Metabolismo do Cálcio/genética , Sinalização do Cálcio , Humanos , Transporte Proteico , Receptores de Detecção de Cálcio/genética
10.
Clin Calcium ; 25(2): 189-94, 2015 Feb.
Artigo em Japonês | MEDLINE | ID: mdl-25634043

RESUMO

Bone and calcium metabolism disorders are closely linked with dementia. Screening for dementia is important since chronic hypercalcemia and hypocalcemia resulting from parathyroid function abnormalities can become a cause of dementia onset. In recent years, it has become clear that vitamin D deficiencies inducing cardiovascular disease and other factors are involved in the pathogenesis of various diseases that in turn become risk factors in dementia, especially Alzheimer's disease. Moreover, osteoporosis and dementia both commonly occur among the elderly. Treating dementia patients for osteoporosis is important since fragility fractures, especially femoral neck fractures, resulting from osteoporosis greatly affect the prognosis of patients with dementia.


Assuntos
Osso e Ossos/metabolismo , Distúrbios do Metabolismo do Cálcio/metabolismo , Cálcio/metabolismo , Demência/metabolismo , Osteoporose/metabolismo , Animais , Distúrbios do Metabolismo do Cálcio/complicações , Distúrbios do Metabolismo do Cálcio/terapia , Cognição/fisiologia , Demência/complicações , Demência/terapia , Humanos , Osteoporose/complicações , Osteoporose/terapia
11.
Int J Oncol ; 45(4): 1355-62, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25069966

RESUMO

Calcium participates in most of the biological processes in the human body. The calcium sensing receptor (CaSR), as an important regulator of calcium homeostasis, is expressed in all of the organs of the digestive system. CaSR plays a key role in gastrointestinal physiological function and in the occurrence of digestive disease. For example, the inactivation or mutation of the CaSR gene usually leads to one of several disorders of calcium metabolism. High dietary Ca2+ may stimulate CaSR activation and could both inhibit tumor development and increase the chemotherapeutic sensitivity of cancer cells in colon cancer tissues. Further, CaSR has also been reported to have a potential role in the treatment for diarrheal diseases and the form of pancreatitis that is associated with carbonate stones. Therefore, CaSR is an important target for treating digestive diseases, and the calcimimetics (CaSR agonist) have been confirmed as practical, feasible and effective clinical therapies for hyperparathyroidism. This review intends to explore the role of CaSR in digestive physiology and pathophysiology as well as current treatments utilizing CaSR­based therapeutics.


Assuntos
Cálcio/metabolismo , Gastroenteropatias/patologia , Receptores de Detecção de Cálcio/genética , Receptores de Detecção de Cálcio/metabolismo , Animais , Distúrbios do Metabolismo do Cálcio/metabolismo , Distúrbios do Metabolismo do Cálcio/patologia , Fenômenos Fisiológicos do Sistema Digestório , Gastroenteropatias/tratamento farmacológico , Gastroenteropatias/genética , Gastroenteropatias/metabolismo , Humanos , Terapia de Alvo Molecular , Receptores de Detecção de Cálcio/agonistas
13.
Pediatr Nephrol ; 28(8): 1195-206, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23142866

RESUMO

Disorders of calcium and magnesium balance are physiologically interesting and clinically challenging. In this review, we attempt to bridge the gap between physiology and practice by providing a physiology-based approach to understanding hypocalcemia, hypercalcemia and hypomagnesemia. Calcium and, to a lesser extent, magnesium balance is achieved through a complex interplay between the parathyroid gland, bone, the intestine and the kidney. Our understanding of the molecular physiology of calcium and magnesium balance has grown considerably following the discovery of the calcium-sensing receptor (CaSR) and the main intestinal and renal transporters for calcium and magnesium, namely, the transient receptor potential channels TRPV5, TRPV6 and TRPM6. The regulation of parathyroid hormone (PTH) secretion by CaSR and the subsequent effects of PTH and vitamin D on TRPV5 constitute an increasingly characterized regulatory loop. In contrast, no truly magnesiotropic hormones have been identified, although the recently established interactions between the epidermal growth factor and TRPM6 suggest a possible candidate. Overall, the aim of this review is to illustrate the clinical disorders of calcium and magnesium balance from the perspective of their integrated physiology.


Assuntos
Distúrbios do Metabolismo do Cálcio/metabolismo , Cálcio/metabolismo , Magnésio/metabolismo , Animais , Distúrbios do Metabolismo do Cálcio/fisiopatologia , Homeostase , Humanos , Hipercalcemia/metabolismo , Hipercalcemia/fisiopatologia , Hipocalcemia/metabolismo , Hipocalcemia/fisiopatologia , Deficiência de Magnésio/metabolismo , Deficiência de Magnésio/fisiopatologia
14.
Prog Cardiovasc Dis ; 55(1): 77-86, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22824113

RESUMO

A synchronized dyshomeostasis of extra- and intracellular Ca(2+), expressed as plasma ionized hypocalcemia and excessive intracellular Ca(2+) accumulation, respectively, represents a common pathophysiologic scenario that accompanies several diverse disorders. These include low-renin and salt-sensitive hypertension, primary aldosteronism and hyperparathyroidism, congestive heart failure, acute and chronic hyperadrenergic stressor states, high dietary Na(+), and low dietary Ca(2+) with hypovitaminosis D. Homeostatic responses are invoked to restore normal extracellular [Ca(2+)](o), including increased plasma levels of parathyroid hormone and 1,25(OH)(2)D(3). However, in cardiomyocytes these calcitropic hormones concurrently promote cytosolic free [Ca(2+)](i) and mitochondrial [Ca(2+)](m) overloading. The latter sets into motion organellar-based oxidative stress, in which the rate of reactive oxygen species generation overwhelms their detoxification by endogenous antioxidant defenses, including those related to intrinsically coupled increments in intracellular Zn(2+). In turn, the opening potential of the mitochondrial permeability transition pore increases, allowing for osmotic swelling and ensuing organellar degeneration. Collectively, these pathophysiologic events represent the major components to a mitochondriocentric signal-transducer-effector pathway to cardiomyocyte necrosis. From necrotic cells, there follows a spillage of intracellular contents, including troponins, and a subsequent wound healing response with reparative fibrosis or scarring. Taken together, the loss of terminally differentiated cardiomyocytes from this postmitotic organ and the ensuing replacement fibrosis each contribute to the adverse structural remodeling of myocardium and progressive nature of heart failure. In conclusion, hormone-induced ionized hypocalcemia and intracellular Ca(2+) overloading comprise a pathophysiologic cascade common to diverse disorders and that initiates a mitochondriocentric pathway to nonischemic cardiomyocyte necrosis.


Assuntos
Distúrbios do Metabolismo do Cálcio/complicações , Cálcio/metabolismo , Cardiopatias/etiologia , Hormônios/metabolismo , Miócitos Cardíacos/metabolismo , Animais , Distúrbios do Metabolismo do Cálcio/metabolismo , Distúrbios do Metabolismo do Cálcio/patologia , Sinalização do Cálcio , Fibrose , Cardiopatias/metabolismo , Cardiopatias/patologia , Homeostase , Humanos , Hipocalcemia/complicações , Hipocalcemia/metabolismo , Hipocalcemia/patologia , Mitocôndrias Cardíacas/metabolismo , Miócitos Cardíacos/patologia , Necrose , Estresse Oxidativo
15.
Clin Biochem ; 45(12): 943-53, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22503956

RESUMO

Following the discovery of the calcium-sensing receptor (CaSR) in 1993, its pivotal role in disorders of calcium homeostasis such as Familial Hypocalciuric Hypercalcemia (FHH) was quickly demonstrated. Since then, it has become clear that the CaSR has immense functional versatility largely through its ability to activate many different signaling pathways in a ligand- and tissue-specific manner. This allows the receptor to play diverse and crucial roles in human physiology and pathophysiology, both in calcium homeostasis and in tissues and biological processes unrelated to calcium balance. This review covers current knowledge of the role of the CaSR in disorders of calcium homeostasis (FHH, neonatal severe hyperparathyroidism, autosomal dominant hypocalcemia, primary and secondary hyperparathyroidism, hypercalcemia of malignancy) as well as unrelated diseases such as breast and colorectal cancer (where the receptor appears to play a tumor suppressor role), Alzheimer's disease, pancreatitis, diabetes mellitus, hypertension and bone and gastrointestinal disorders. In addition, it examines the use or potential use of CaSR agonists or antagonists (calcimimetics and calcilytics) and other drugs mediated through the CaSR, in the management of disorders as diverse as hyperparathyroidism, osteoporosis and gastrointestinal disease.


Assuntos
Receptores de Detecção de Cálcio/fisiologia , Animais , Doenças Ósseas/tratamento farmacológico , Doenças Ósseas/metabolismo , Encefalopatias/metabolismo , Distúrbios do Metabolismo do Cálcio/etiologia , Distúrbios do Metabolismo do Cálcio/metabolismo , Doenças Cardiovasculares/metabolismo , Gastroenteropatias/metabolismo , Humanos , Hiperparatireoidismo/metabolismo , Mutação , Neoplasias/complicações , Neoplasias/metabolismo , Receptores de Detecção de Cálcio/genética , Receptores de Detecção de Cálcio/metabolismo
16.
Klin Med (Mosk) ; 89(4): 13-7, 2011.
Artigo em Russo | MEDLINE | ID: mdl-21932554

RESUMO

The authors present literature data on the role of Ca-P metabolism and its regulators in the development of bone and cardiovascular pathology, intrauterine development, organogenesis, cell growth and differentiation. A large number of agents are currently available to modify Ca-P metabolism. (calcium and vitamin Dpreparations, PTH, calcitonin, stimulators of Ca-sensitive receptors, calcitriol receptor ligands, etc.) although their application is hampered by the dificulty of laboratory control and the lack of basic knowledge. It is maintained that raising awareness among practitioners about these issues may improve diagnostics of Ca-P metabolic disorders (in the first place, calcium and vitamin D deficiency, secondary hyperthyroidism) and promote their medicamental and non-medicamental therapy.


Assuntos
Doenças Ósseas/etiologia , Distúrbios do Metabolismo do Cálcio/metabolismo , Cálcio/metabolismo , Doenças Cardiovasculares/etiologia , Distúrbios do Metabolismo do Cálcio/complicações , Distúrbios do Metabolismo do Cálcio/tratamento farmacológico , Diferenciação Celular , Desenvolvimento Embrionário , Humanos , Hiperparatireoidismo Secundário/diagnóstico , Hiperparatireoidismo Secundário/tratamento farmacológico , Organogênese , Deficiência de Vitamina D/diagnóstico , Deficiência de Vitamina D/tratamento farmacológico
17.
Biochem Biophys Res Commun ; 409(2): 287-92, 2011 Jun 03.
Artigo em Inglês | MEDLINE | ID: mdl-21575598

RESUMO

Abnormalities in intracellular Ca(2+) handing are believed to contribute to arrhythmogenesis during atrial fibrillation (AF). Ca(2+)/calmodulin-dependent protein kinaseII δ (CaMKIIδ) overexpression was detected in atrial myocytes from patients and animal models with persistent AF. In the present study, we found that rapid electrical field stimulation applied to primary atrial myocytes altered the CaMKIIδ activity, not expression level, resulting in Ca(2+) disorder. By lentivirus mediated delivery of CaMKIIδ gene or siRNA into atrial myocytes, cells with different CaMKIIδ expression were generated. Changes of CaMKIIδ expression altered the sarcoplasmic reticulum (SR) Ca(2+) release and L-type Ca(2+) channels current (I(Ca)) in both steady and electrical stimulating state. These results revealed the important role of CaMKIIδ in Ca(2+) disorder caused by electrical field stimulation. It also provided a potential method to improve Ca(2+) disorder in AF by modulating CaMKIIδ expression level.


Assuntos
Distúrbios do Metabolismo do Cálcio/metabolismo , Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina/biossíntese , Cálcio/metabolismo , Átrios do Coração/citologia , Miócitos Cardíacos/metabolismo , Animais , Células Cultivadas , Estimulação Elétrica , Ratos , Retículo Sarcoplasmático/metabolismo
18.
Artigo em Inglês | MEDLINE | ID: mdl-21441595

RESUMO

The endoplasmic reticulum (ER) as an intracellular Ca(2+) store not only sets up cytosolic Ca(2+) signals, but, among other functions, also assembles and folds newly synthesized proteins. Alterations in ER homeostasis, including severe Ca(2+) depletion, are an upstream event in the pathophysiology of many diseases. On the one hand, insufficient release of activator Ca(2+) may no longer sustain essential cell functions. On the other hand, loss of luminal Ca(2+) causes ER stress and activates an unfolded protein response, which, depending on the duration and severity of the stress, can reestablish normal ER function or lead to cell death. We will review these various diseases by mainly focusing on the mechanisms that cause ER Ca(2+) depletion.


Assuntos
Distúrbios do Metabolismo do Cálcio/metabolismo , Sinalização do Cálcio , Cálcio/metabolismo , Retículo Endoplasmático/fisiologia , Modelos Biológicos , Apoptose , Distúrbios do Metabolismo do Cálcio/patologia , Retículo Endoplasmático/metabolismo , Homeostase , Humanos , Dobramento de Proteína
19.
Pediatr Nephrol ; 26(6): 933-7, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21340610

RESUMO

Data on conservative treatment in children with urolithiasis are limited. The aim of the study was to determine the metabolic etiology and results of conservative treatment in children with urolithiasis. We evaluated the clinical presentation and metabolic features of 112 children with urolithiasis. The mean age at diagnosis of urolithiasis was 3.9 (range 0.1-18) years, and follow-up duration was 16.7 (range 1-36) months. The most common presenting symptoms were flank or abdominal pain and restlessness (25%). Urine analysis revealed metabolic abnormalities in 92% of cases, including hypocitraturia (42%), hyperoxaluria (32.1%), hypercalcuria (25%), hyperuricosuria (9.8%), and cystinuria (2.7%). Patients who had metabolic risk factors were treated according to underlying metabolic abnormalities. About half of these patients were stone free or stones were diminished in size. These results showed that early recognition and treatment of urinary metabolic abnormalities will reduce the number of invasive procedures and renal damage in children with urolithiasis.


Assuntos
Distúrbios do Metabolismo do Cálcio/dietoterapia , Urolitíase/dietoterapia , Adolescente , Distúrbios do Metabolismo do Cálcio/complicações , Distúrbios do Metabolismo do Cálcio/metabolismo , Criança , Pré-Escolar , Ácido Cítrico/urina , Cistinúria/diagnóstico , Cistinúria/urina , Feminino , Humanos , Hipercalciúria/diagnóstico , Hipercalciúria/urina , Hiperoxalúria/diagnóstico , Hiperoxalúria/urina , Lactente , Masculino , Fosfatos/urina , Estudos Prospectivos , Fatores de Risco , Resultado do Tratamento , Ácido Úrico/urina , Urinálise , Urolitíase/complicações , Urolitíase/metabolismo
20.
J Mater Sci Mater Med ; 21(5): 1531-42, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20232236

RESUMO

The aim of this study was to evaluate the bioactivity of hydroxyapatite films composed of hexagonal single crystals that display {1010} and {0001} crystallographic faces. The effect of engineered [0001] crystallographic orientation was investigated in parallel. Films were deposited by triethyl phosphate/ethylenediamine-tetraacetic acid doubly regulated hydrothermal crystallization on Ti6Al4V substrates (10, 14, 24 h). Bioactivity was investigated by analysis of MC3T3-E1 pre-osteoblast spreading using scanning electron microscopy and quantitative analysis of cell metabolic activity (Alamar Blue) (0-28 days). Scanning electron microscopy and X-ray diffraction were used to evaluate the ability of films to support the differentiation of MC3T3-E1 pre-osteoblasts into matrix-secreting, mineralizing osteoblasts. Results demonstrated that all films enabled MC3T3-E1 cells to spread, grow, and differentiate into matrix-secreting osteoblasts, which deposited biomineral that could not be removed after extraction of organic material. Differences in [0001] HA crystallographic orientation were not, however, found to significantly affect bioactivity. Based on these results, it is concluded that these hydrothermal hydroxyapatite films are non-toxic, bioactive, osteoconductive, and biomineral bonding. The lack of a relationship between reported hydroxyapatite crystallographic face specific protein adsorption and bulk HA bioactivity are discussed in terms of crystallographic texture, surface roughness, assay robustness, and competitive protein adsorption.


Assuntos
Durapatita/química , Osteoblastos/citologia , Ligas , Animais , Distúrbios do Metabolismo do Cálcio/metabolismo , Células Clonais , Cristalização/métodos , Cristalografia , Durapatita/metabolismo , Durapatita/farmacologia , Camundongos , Microscopia Eletrônica de Varredura , Osteoblastos/efeitos dos fármacos , Osteoblastos/metabolismo , Oxazinas , Titânio , Difração de Raios X , Raios X , Xantenos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...